Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Liem Nguyen. (2012) Targeting antibiotic resistance mechanisms in Mycobacterium tuberculosis: recharging the old magic bullets. Expert Review of Anti-infective Therapy 10:9, pages 963-965.
Read now
Read now
Articles from other publishers (14)
Zhi-Chao Yu, Yong-Xin Cen, Ben-Hua Wu, Cheng Wei, Feng Xiong, De-Feng Li, Ting-Ting Liu, Ming-Han Luo, Li-Liangzi Guo, Ying-Xue Li, Li-Sheng Wang, Jian-Yao Wang & Jun Yao. (2019) Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats. World Journal of Gastroenterology 25:29, pages 3956-3971.
Crossref
Crossref
Guangming Dai, Suting Chen, Lingling Dong, Yun Xu Li, Fengmin Huo, Yuanyuan Shang & Hairong Huang. (2019) Determination of the Critical Concentration of Rifabutin for Susceptibility Testing Using the Proportion Method with Löwenstein-Jensen Medium against Mycobacterium Tuberculosis Isolates. Laboratory Medicine 50:3, pages 292-297.
Crossref
Crossref
Maha R Farhat, Jaimie Sixsmith, Roger Calderon, Nathan D Hicks, Sarah M Fortune & Megan Murray. (2019) Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates. Journal of Antimicrobial Chemotherapy 74:6, pages 1477-1483.
Crossref
Crossref
Hyun Lee, Soohyun Ahn, Na Young Hwang, Kyeongman Jeon, O Jung Kwon, Hee Jae Huh, Nam Yong Lee & Won-Jung Koh. (2017) Treatment outcomes of rifabutin-containing regimens for rifabutin-sensitive multidrug-resistant pulmonary tuberculosis. International Journal of Infectious Diseases 65, pages 135-141.
Crossref
Crossref
Sandeep Sharma & Noton K. Dutta. (2017) Commentary: Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates. Frontiers in Microbiology 8.
Crossref
Crossref
Noton K. Dutta & Petros C. Karakousis. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
359
383
.
Yoann Crabol, Emilie Catherinot, Nicolas Veziris, Vincent Jullien & Olivier Lortholary. (2016) Rifabutin: where do we stand in 2016?. Journal of Antimicrobial Chemotherapy 71:7, pages 1759-1771.
Crossref
Crossref
David J. Farrell. (2013) Rifaximin in the Treatment of Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 47:3, pages 205-211.
Crossref
Crossref
Kyung-Wook Jo, Wonjun Ji, Yoonki Hong, Sang-Do Lee, Woo Sung Kim, Dong Soon Kim & Tae Sun Shim. (2013) The efficacy of rifabutin for rifabutin-susceptible, multidrug-resistant tuberculosis. Respiratory Medicine 107:2, pages 292-297.
Crossref
Crossref
Huang-Yao Chen, Ming-Chih Yu, Wei-Lun Huang, Mei-Hua Wu, Yung-Lin Chang, Chien-Rai Che & Ruwen Jou. (2012) Molecular Detection of Rifabutin-Susceptible Mycobacterium tuberculosis. Journal of Clinical Microbiology 50:6, pages 2085-2088.
Crossref
Crossref
Petros C. Karakousis. 2009. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
271
291
.
C. Bicmen, A.T. Gunduz, M. Coskun, G. Senol, N. Ozkutuk, A.K. Cirak & R. Ozacar. (2008)
Molecular identification and characterization of rifampicin-resistant
Mycobacterium tuberculosis
isolates by line probe assay: an approach for rapid diagnosis of multidrug-resistant tuberculosis
. Letters in Applied Microbiology 47:3, pages 214-220.
Crossref
Crossref
M. Sousa, A. Pozniak & M. Boffito. (2008) Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs. Journal of Antimicrobial Chemotherapy 62:5, pages 872-878.
Crossref
Crossref
Byoung Ju KimSeung Hwan OhEun Jin ChoSeung Kyu Park. (2006) Cross-resistance Between Rifampicin and Rifabutin and Its Relationship with rpoB Gene Mutations in Clinically Isolated MDR-TB Strains. Tuberculosis and Respiratory Diseases 60:2, pages 171.
Crossref
Crossref